Prelude Capital Management’s New Frontier Health Corporation Ordinary Shares NFH Stock Holding History

Prelude Capital Management’s Portfolio NFH Stock Details NFH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-159,496	Closed	-$1.83M	–	2523
2021 Q4	$1.83M	Buy	159,496 +77,896	+95%	+$878K	0.05%	348
2021 Q3	$916K	Hold	81,600	–	–	0.02%	606
2021 Q2	$911K	Sell	81,600 -16,000	-16%	-$179K	0.03%	661
2021 Q1	$1.1M	Buy	97,600 +23,630	+32%	+$240K	0.03%	559
2020 Q4	$636K	Buy	73,970 +54,500	+280%	+$470K	0.02%	631
2020 Q3	$149K	Buy	+19,470	New	+$160K	0.01%	774

Other funds holding NFH

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Prelude Capital Management's NFH Position: Q1 2022 in Review

Prelude Capital Management sold out of New Frontier Health Corporation Ordinary Shares (NFH) in Q1 2022, closing a stake of 159,496 shares — an estimated $1.83M sold.

Prelude Capital Management first reported a position in NFH in Q3 2020 and held it in 6 quarters. The position peaked at $1.83M in Q4 2021. 2 funds tracked by Wall St. Rank hold NFH as of Q1 2022.

Prelude Capital Management reported no remaining New Frontier Health Corporation Ordinary Shares position as of Q1 2022 after selling out during the quarter.
Prelude Capital Management sold 159,496 New Frontier Health Corporation Ordinary Shares shares in Q1 2022, an estimated $1.83M.
Prelude Capital Management first reported a position in New Frontier Health Corporation Ordinary Shares in Q3 2020 and held it in 6 quarters.
Prelude Capital Management's New Frontier Health Corporation Ordinary Shares position peaked at $1.83M in Q4 2021.
2 funds tracked by Wall St. Rank held New Frontier Health Corporation Ordinary Shares as of Q1 2022.

Based on Prelude Capital Management's 13F filing for Q1 2022, filed 16 May 2022.